Evidence map›Paper›PMID 41015973›Full record

ReviewCell regeneration (London, England)2025

Rewiring cell identity and metabolism to drive cardiomyocyte proliferation.

Lixia Zheng, Yuanyuan Chen, Jing-Wei Xiong

Abstract readReview
In one paragraph

Review in Cell regeneration (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lixia Zheng *Beijing Key Laboratory of Cardiometabolic Molecular Medicine, and, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, 100871, China. zhenglixia@pku.edu.cn.ORCID http://orcid.org/0009-0001-8809-3875
Yuanyuan Chen *Beijing Key Laboratory of Cardiometabolic Molecular Medicine, and, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, 100871, China.
Jing-Wei XiongBeijing Key Laboratory of Cardiometabolic Molecular Medicine, and, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, 100871, China. jingwei_xiong@pku.edu.cn.ORCID http://orcid.org/0000-0001-8438-4782

Funding

GanPo Senior Investigator Award gpyc20240020Key Technologies Research and Development Program 2018YFA0800501Key Technologies Research and Development Program 2019YFA0801602Key Technologies Research and Development Program (2023YFA1800600National Science Foundation 31730061National Science Foundation 32230032National Science Foundation 82400316
6 · The paper itself

Abstract

The adult mammalian heart exhibits minimal regenerative capacity due to postnatal cell-cycle arrest of cardiomyocytes. In contrast, lower vertebrates such as zebrafish retain the ability to fully regenerate heart after injury. This capacity is driven not only by transcriptional and structural plasticity but also by metabolic reprogramming that supports cardiomyocyte proliferation. Adult mammalian cardiomyocytes lack both features, remaining largely refractory to regenerative cues. These limitations have prompted efforts to identify extrinsic genetic and metabolic regulators capable of reactivating proliferative competence in adult cardiomyocytes. In this review, we highlight recent advances in the molecular and metabolic control of cardiomyocyte cell-cycle reentry, focusing on strategies that modulate dedifferentiation, proliferation, and redifferentiation as well as metabolic state transitions. We also examine emerging translational approaches in swine models, which more closely recapitulate human cardiac physiology than rodents. Together, these insights provide a roadmap for unlocking endogenous regenerative pathways and identify key challenges in translating these findings into therapies for heart failure.

Indexed as

Cardiomyocyte proliferationDedifferentiationHeart regenerationMetabolic reprogrammingSwine

Identifiers

PMID41015973
PMCPMC12477098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.